Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRα-positive, platinum resistant ovarian cancer in Germany.

Janke FF et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 221049
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.